On a new Behind the Markets podcast, Jeremy Schwartz speaks with Corey Hoffstein of Newfound Research and Rodrigo Gordillo of ReSolve Asset Management about their new paper, “Return Stacking™,” on how to leverage to seek to boost returns.
Many investors have preconceived notions about hedging currency risk in their international equity investments. Jeremy Schwartz and Jeff Weniger seek to challenge the status quo, making the case for hedging your currency bets.
FAMGA’s ability to use M&A is coming under fire, and it’s making an impact on how the big tech monopolies think about growth. Alex Moazed and Jeremy Schwartz explains how this scrutiny is making way for mid-market tech companies.
A little more than three years ago, we launched our WisdomTree U.S. Efficient Core Fund (NTSX). Since the launch, this Fund has outperformed the S&P 500 with fewer drawdowns. Jeremy Schwartz and Brad Krom discuss why now is the right time to reconsider how NTSX could enhance your portfolio.
On this episode of Behind the Markets, Jeremy Schwartz speaks with Tom Ricketts, President & CIO of Evolutionary Tree Capital Management, about the rise of innovation investing as a new investment style.
WisdomTree has collaborated with Dr. Jamie Metzl to help create the underlying Index that the BioRevolution Fund (WDNA) seeks to track. Dr. Metzl is the author of Hacking Darwin: Genetic Engineering and the Future of Humanity and a member of the World Health Organization’s advisory committee on human genome editing. Along with our Jeremy Schwartz, he discusses the BioRevolution, WDNA and the blurring lines between science fiction and our new reality.
